Might Vioxx make a backdoor comeback? 2017 Vioxx went off patent, now a small pharma has applied to the FDA for orphan drug approval of rofecoxib (& etoricoxib) to treat hemophiliac arthropathy (large unmet need). Say it aint so! https://t.co/kENHHhcyIT https://t.co/QpDNiaCZyz
Links:
Fool Me Twice? The Reemergence of Rofecoxib and the Orphan Drug Act | Annals o…
http://bit.ly/2p3HSM5
Shocker! Is Vioxx Coming Back... as an Orphan Drug? | Medpage Today
http://bit.ly/2nulYRz
Oct-03-2019
